BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2059298)

  • 1. Renal allograft immunosuppression. III. Triple therapy versus three different combinations of double drug treatment: two year results in kidney transplant patients.
    Isoniemi H
    Transpl Int; 1991 Apr; 4(1):31-7. PubMed ID: 2059298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal allograft immunosuppression. II. A randomized trial of withdrawal of one drug in triple drug immunosuppression.
    Isoniemi H; Ahonen J; Eklund B; Höckerstedt K; Salmela K; von Willebrand E; Häyry P
    Transpl Int; 1990 Oct; 3(3):121-7. PubMed ID: 2271083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal allograft immunosuppression. VI. Triple drug therapy versus immunosuppressive double drug combinations: histopathological findings in renal allografts.
    Isoniemi H; Krogerus L; von Willebrand E; Taskinen E; Grönhagen-Riska C; Ahonen J; Häyry P
    Transpl Int; 1991 Sep; 4(3):151-6. PubMed ID: 1958279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal allograft immunosuppression. IV. Comparison of lipid and lipoprotein profiles in blood using double and triple immunosuppressive drug combinations.
    Isoniemi H; Tikkanen MJ; Ahonen J; Häyry P
    Transpl Int; 1991 Sep; 4(3):130-5. PubMed ID: 1958276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal allograft immunosuppression. I. Early inflammatory and rejection episodes in triple drug treatment compared to double drug combinations or cyclosporin monotherapy.
    Isoniemi H; Ahonen J; Eklund B; Höckerstedt K; Salmela K; von Willebrand E; Häyry P
    Transpl Int; 1990 Jul; 3(2):92-7. PubMed ID: 2206227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term renal allograft function under maintenance immunosuppression with cyclosporin A or azathioprine. A single center, five-year follow-up study.
    Linder R; Lindholm A; Restifo A; Duraj F; Groth CG
    Transpl Int; 1991 Sep; 4(3):166-72. PubMed ID: 1958282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term consequences of different immunosuppressive regimens for renal allografts.
    Isoniemi HM; Ahonen J; Tikkanen MJ; von Willebrand EO; Krogerus L; Eklund BH; Höckerstedt KV; Salmela KE; Häyry PJ
    Transplantation; 1993 Mar; 55(3):494-9. PubMed ID: 8456467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcome after switch from cyclosporine-based triple-drug immunosuppression to double therapy at three months.
    Aichberger C; Eberl T; Riedmann B; Pernthaler H; Ofner D; Königsrainer A; Margreiter R
    Clin Transplant; 1996 Apr; 10(2):209-12. PubMed ID: 8664521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized trial comparing triple-drug and double-drug therapy in renal transplantation.
    Ponticelli C; Tarantino A; Montagnino G; Aroldi A; Banfi G; De Vecchi A; Zubani R; Berardinelli L; Vegeto A
    Transplantation; 1988 May; 45(5):913-8. PubMed ID: 3285536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomised controlled trial of steroid withdrawal in renal transplant recipients receiving triple immunosuppression.
    Ratcliffe PJ; Dudley CR; Higgins RM; Firth JD; Smith B; Morris PJ
    Lancet; 1996 Sep; 348(9028):643-8. PubMed ID: 8782754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Optimal dose of cyclosporin in living related kidney transplantation].
    Tanabe K; Takahashi K; Sonda K; Yagisawa T; Oba S; Nakazawa H; Goya N; Yamaguchi Y; Fuchinoue S; Nakamura M
    Nihon Hinyokika Gakkai Zasshi; 1992 Apr; 83(4):528-35. PubMed ID: 1593833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effectiveness and safety of conversion therapy with the combination of sirolimus with low dose cyclosporine in renal transplantation recipients: a five-year clinical observation].
    Zhu L; Ding T; Wang XX; Lin ZB; Chen G
    Zhonghua Yi Xue Za Zhi; 2016 May; 96(20):1556-61. PubMed ID: 27266681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detrimental effects of cyclosporin A on long-term graft survival in familial Mediterranean fever renal allograft recipients: experience of two transplantation centers.
    Shabtai M; Ben-Haim M; Zemer D; Malinger-Saavedra P; Rosin D; Kuriansky J; Lustig S; Shabtai EL; Shapira Z; Ayalon A
    Isr Med Assoc J; 2002 Nov; 4(11 Suppl):935-9. PubMed ID: 12455184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose cyclosporin A therapy in cadaver renal transplantation in children.
    Ruder H; Strehlau J; Schaefer F; Gretz N; Müller-Wiefel DE; Bonzel KE; Möhring K; Pomer S; Mehls O; Schärer K
    Transpl Int; 1989 Dec; 2(4):203-8. PubMed ID: 2697210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amelioration of chronic renal allograft dysfunction in cyclosporine-treated patients by addition of azathioprine.
    Rocher LL; Hodgson RJ; Merion RM; Swartz RD; Keavey S; Turcotte JG; Campbell DA
    Transplantation; 1989 Feb; 47(2):249-54. PubMed ID: 2645707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
    Anil Kumar MS; Irfan Saeed M; Ranganna K; Malat G; Sustento-Reodica N; Kumar AM; Meyers WC
    Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Azathioprine-cyclosporin A (CyA) double therapy versus CyA alone after the first rejection episode in kidney-transplanted patients under CyA. A randomized study.
    Hourmant M; Taupin JL; Leymerigie F; Cantarovich D; Soulillou JP
    Transpl Int; 1989 Aug; 2(2):113-6. PubMed ID: 2675895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single bolus antithymocyte globulin versus basiliximab induction in kidney transplantation with cyclosporine triple immunosuppression: efficacy and safety.
    Kyllönen LE; Eklund BH; Pesonen EJ; Salmela KT
    Transplantation; 2007 Jul; 84(1):75-82. PubMed ID: 17627241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal transplantation at Hartford Hospital: results of combined and flexible immunosuppression.
    Schweizer RT; Bow L; Roper L; Hull D; Bartus SA
    Clin Transpl; 1988; ():147-58. PubMed ID: 3154467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term graft outcome in patients with chronic allograft dysfunction after immunosuppression modifications.
    El-Agroudy AE; El-Dahshan K; Mahmoud K; El-Baz M; Shokeir AA; Ghoneim MA
    Ann Transplant; 2008; 13(4):46-54. PubMed ID: 19034223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.